Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis

Journal of Cell Science

Volumn 118, Issue 4, 2005, Pages 819-829

  Lee, Ming Kei ^a   Hande, M Prakash ^b   Sabapathy, Kanaga ^a,b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Apoptosis; Differentiation; ES cells; mTERT; p53; Stress signals

Indexed keywords

PROTEIN P53; PROTEIN SUBUNIT; RIBONUCLEOPROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CATALYSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; CHROMOSOME REPLICATION; CONTROLLED STUDY; DNA VECTOR; DRUG ACTIVITY; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENOTOXICITY; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TELOMERE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA-BINDING PROTEINS; EMBRYO; GENE EXPRESSION; MICE; OXIDATIVE STRESS; STEM CELLS; TELOMERASE; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 14944345009     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01673     Document Type: Article

References (64)

1. Abe, K., Niwa, H., Iwase, K., Takiguchi, M., Mori, M., Abe, S. I., Abe, K. and Yamamura, K. I. (1996). Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies. Exp. Cell Res. 229, 27-34.
2. Akiyama, M., Yamada, O., Kanda, N., Akita, S., Kawano, T., Ohno, T., Mizoguchi, H., Eto, Y., Anderson, K. C. and Yamada, H. (2002). Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors. Cancer Lett. 178, 187-197.
3. Arakawa, H., Lodygin, D. and Buerstedde, J. M. (2001). Mutant loxP vectors for selectable marker recycle and conditional knock-outs. BMC Biotechnol. 1, 7.
4. Arceci, R. J., King, A. A., Simon, M. C., Orkin, S. H. and Wilson, D. B. (1993). Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol. Cell. Biol. 13, 2235-2246.
5. Armstrong, L., Lako, M., Lincoln, J., Cairns, P. M. and Hole, N. (2000). mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. Mech. Dev. 97, 109-116.
6. Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., Greenberg, R. A., Castrillon, D. H., Horner, J. W., Weiler, S. R., Carrasco, R. D. et al. (2002). Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl. Acad. Sci. USA 99, 8191-8196.
7. Blum, M., Gaunt, S. J., Cho, K. W., Steinbeisser, H., Blumberg, B., Bittner, D. and De Robertis, E. M. (1992). Gastrulation in the mouse: the role of the homeobox gene goosecoid. Cell 69 1097-1106.
8. Camphausen, K., Burgan, W., Cerra, M., Oswald, K. A., Trepel, J. B., Lee, M. J. and Tofilon, P. J. (2004). Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275. Cancer Res. 64, 316-321.
9. Cao, Y., Li, H., Deb, S. and Liu, J. P. (2002). TERT regulates cell survival independent of telomerase enzymatic activity. Oncogene 21, 3130-3138.
10. Castro-Obregon, S. and Covarrubias, L. (1996). Role of retinoic acid and oxidative stress in embryonic stem cell death and neuronal differentiation. FEBS Lett. 381, 93-97.
11. Cerezo, A., Stark, H. J., Moshir, S. and Boukamp, P. (2003). Constitutive overexpression of human telomerase reverse transcriptase but not c-myc blocks terminal differentiation in human HaCaT skin keratinocytes. J. Invest. Dermatol. 121, 110-119.
12. Collins, K. and Mitchell, J. R. (2002). Telomerase in the human organism. Oncogene 21, 564-579.
13. de Vries, A., Flores, E. R., Miranda, B., Hsieh, H. M., van Oostrom, C. T., Sage, J. and Jacks, T. (2002). Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function. Proc. Natl. Acad. Sci. USA 99, 2948-2953.
14. Fu, W., Begley, J. G., Killen, M. W. and Mattson, M. P. (1999). Antiapoptotic role of telomerase in pheochromocytoma cells. J. Biol. Chem. 274, 7264-7271.
15. Fu, W., Killen, M., Culmsee, C., Dhar, S., Pandita, T. K. and Mattson, M. P. (2000). The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J. Mol. Neurosci. 14, 3-15.
16. Gonzalez-Suarez, E., Flores, J. M. and Blasco, M. A. (2002). Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development. Mol. Cell. Biol. 22, 7291-7301.
17. Gorbunova, V., Seluanov, A. and Pereira-Smith, O. M. (2002). Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis. J. Biol. Chem. 277, 38540-38549.
18. Greenberg, R. A., Allsopp, R. C., Chin, L., Morin, G. B. and DePinho, R. A. (1998). Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723-1730.
19. Kemler, R. (1980). Analysis of mouse embryonic cell differentiation. In Progress in Developmental Biology (ed. H. W. Saner), pp. 175-181. Stuttgart, Germany: Gustav Fischer Verlag.
20. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L. and Shay, J. W. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
21. Kipling, D. and Cooke, H. J. (1990). Hypervariable ultra-long telomeres in mice. Nature 347, 400-402.
22. Kobune, M., Kawano, Y., Ito, Y., Chiba, H., Nakamura, K., Tsuda, H., Sasaki, K., Dehari, H., Uchida, H., Honmou, O. et al. (2003). Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. Exp. Hematol. 31, 715-722.
23. Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V. and Gudkov, A. V. (1999). A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733-1737.
24. Komarova, E. A., Neznanov, N., Komarov, P. G., Chernov, M. V., Wang, K. and Gudkov, A. V. (2003). p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways. J. Biol. Chem. 278, 15465-15468.
25. Kondo, Y., Kondo, S., Tanaka, Y., Haqqi, T., Barna, B. P. and Cowell, J. K. (1998). Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene 16, 2243-2248.
26. Koyanagi, Y., Kobayashi, D., Yajima, T., Asanuma, K., Kimura, T., Sato, T., Kida, T., Yagihashi, A., Kameshima, H. and Watanabe, N. (2000). Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells. Anticancer Res. 20, 773-778.
27. Kuefer, R., Hofer, M. D., Altug, V., Zorn, C., Genze, F., Kunzi-Rapp, K., Hautmann, R. E. and Gschwend, J. E. (2004). Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. Br. J. Cancer 90, 535-541.
28. Kushner, D. M., Paranjape, J. M., Bandyopadhyay, B., Cramer, H., Leaman, D. W., Kennedy, A. W., Silverman, R. H. and Cowell, J. K. (2000). 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells. Gynecol. Oncol. 76, 183-192.
29. Liu, S. X., Sun, W. S., Cao, Y. L., Ma, C. H., Han, L. H., Zhang, L. N., Wang, Z. G. and Zhu, F. L. (2004). Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells. World J. Gastroenterol. 10, 366-370.
30. Lu, C., Fu, W. and Mattson, M. P. (2001). Telomerase protects developing neurons against DNA damage-induced cell death. Brain Res. Dev. Brain Res. 131, 167-171.
31. + helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis. Blood 101, 4512-4519.
32. Martin-Rivera, L., Herrera, E., Albar, J. P. and Blasco, M. A. (1998). Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl. Acad. Sci. USA 95, 10471-10476.
33. Misawa, M., Tauchi, T., Sashida, G., Nakajima, A., Abe, K., Ohyashiki, J. H. and Ohyashiki, K. (2002). Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Int. J. Oncol. 21, 1087-1092.
34. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M. and Yamanaka, S. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642.
35. Nakajima, A., Tauchi, T., Sashida, G., Sumi, M., Abe, K., Yamamoto, K., Ohyashiki, J. H. and Ohyashiki, K. (2003). Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy. Leukemia 17, 560-567.
36. Nozawa, K., Maehara, K. and Isobe, K. (2001). Mechanism for the reduction of telomerase expression during muscle cell differentiation. J. Biol. Chem. 276, 22016-22023.
37. Oh, H., Taffet, G. E., Youker, K. A., Entman, M. L., Overbeek, P. A., Michael, L. H. and Schneider, M. D. (2001). Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl. Acad. Sci. USA 98, 10308-10313.
38. Ohali, A., Avigad, S., Cohen, I. J., Meller, I., Kollender, Y., Issakov, J., Gelernter, I., Goshen, Y., Yaniv, I. and Zaizov, R. (2003). Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors. J. Clin. Oncol. 21, 3836-3843.
39. Rahman, R., Latonen, L. and Wiman, K. G. (2004). hTERT antagonizes p53-induced apoptosis independently of telomerase activity. Oncogene Dec 20 [Epub ahead of print].
40. Rama, S., Suresh, Y. and Rao, A. J. (2001). Regulation of telomerase during human placental differentiation: a role for TGFbeta1. Mol. Cell Endocrinol. 182, 233-248.
41. Renoncourt, Y., Carroll, P., Filippi, P., Arce, V. and Alonso, S. (1998). Neurons derived in vitro from ES cells express homeoproteins characteristic of motoneurons and interneurons. Mech. Dev. 79, 185-197.
42. Robertson, E., Bradley, A., Kuehn, M. and Evans, M. (1986). Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 323, 445-448.
43. Rocha, S., Campbell, K. J., Roche, K. C. and Perkins, N. D. (2003). The p53-inhibitor pifithrin-alpha inhibits firefly luciferase activity in vivo and in vitro. BMC Mol. Biol. 4, 9.
44. Rogers, M. B., Hosler, B. A. and Gudas, L. J. (1991). Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. Development 113, 815-824.
45. Rudolph, K. L., Chang, S., Lee, H. W., Blasco, M., Gottlieb, G. J., Greider, C. and DePinho, R. A. (1999). Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712.
46. Sabapathy, K., Klemm, M., Jaenisch, R. and Wagner, E. F. (1997). Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J. 16, 6217-6229.
47. Savatier, P., Huang, S., Szekely, L., Wiman, K. G. and Samarut, J. (1994). Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts. Oncogene 9, 809-818.
48. Schuler, M. and Green, D. R. (2001). Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 29, 684-688.
49. Sharma, H. W., Sokoloski, J. A., Perez, J. R., Maltese, J. Y., Sartorelli, A. C., Stein, C. A., Nichols, G., Khaled, Z., Telang, N. T. and Narayanan, R. (1995). Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA 92, 12343-12346.
50. Shats, I., Milyavsky, M., Erez, N. and Rotter, V. (2003). The murine telomerase catalytic subunit shares the PAb-240 mutant specific epitope of the p53 protein. FEBS Lett. 546, 321-324.
51. Siddik, Z. H. (2003). Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265-7279.
52. Slijepcevic, P. and Bryant, P. E. (1998). Chromosome healing, telomere capture and mechanisms of radiation-induced chromosome breakage. Int. J. Radiat. Biol. 73, 1-13.
53. Suenaga, M., Soda, H., Oka, M., Yamaguchi, A., Nakatomi, K., Shiozawa, K., Kawabata, S., Kasai, T., Yamada, Y., Kamihira, S. et al. (2002). Historic deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. Int. J. Cancer 97, 621-625.
54. Teng, L., Specht, M. C., Barden, C. B. and Fahey, T. J., III (2003). Antisense hTERT inhibits thyroid cancer cell growth. J. Clin. Endocrinol. Metab. 88, 1362-1366.
55. Ulaner, G. A., Huang, H. Y., Otero, J., Zhao, Z., Ben-Porat, L., Satagopan, J. M., Gorlick, R., Meyers, P., Healey, J. H., Huvos, A. G. et al. (2003). Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res. 63, 1759-1763.
56. Urquidi, V., Tarin, D. and Goodison, S. (2000). Role of telomerase in cell senescence and oncogenesis. Annu. Rev. Med. 51, 65-79.
57. Wang, X. (2001). The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922-2933.
58. Xiang, H., Wang, J., Mao, Y., Liu, M., Reddy, V. N. and Li, D. W. (2002). Human telomerase accelerates growth of lens epithelial cells through regulation of the genes mediating RB/E2F pathway. Oncogene 21, 3784-3791.
59. Xu, D., Gruber, A., Bjorkholm, M., Peterson, C. and Pisa, P. (1999). Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br. J. Cancer 80, 1156-1161.
60. Yamada, O., Akiyama, M., Kawauchi, K., Adachi, T., Yamada, H., Kanda, N. and Aikawa, E. (2003). Overexpression of telomerase confers a survival advantage through suppression of TRF1 gene expression while maintaining differentiation characteristics in K562 cells. Cell Transplant. 12, 365-377.
61. Yuan, X., Ishibashi, S., Hatakeyama, S., Saito, M., Nakayama, J., Nikaido, R., Haruyama, T., Watanabe, Y., Iwata, H., Iida, M. et al. (1999). Presence of telomeric G-strand tails in the telomerase catalytic subunit TERT knockout mice. Genes Cells 4 563-572.
62. Yuan, Z. and Mei, H. D. (2002). Inhibition of telomerase activity with hTERT antisense increases the effect of CDDP-induced apoptosis in myeloid leukemia. Hematol. J. 3, 201-205.
63. Zhang, P., Chan, S. L., Fu, W., Mendoza, M. and Mattson, M. P. (2003). TERT suppresses apoptotis at a premitochondrial step by a mechanism requiring reverse transcriptase activity and 14-3-3 protein-binding ability. FASEB J. 17, 767-769.
64. Zhu H., Fu, W. and Mattson, M. P. (2000). The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J. Neurochem. 75, 117-124.